Routine use of outcome measures in therapy is still rare: in one US national survey, only 13.9% of clinicians used standardised progress measures at least monthly. The data gets collected, filed, and forgotten. If your practice is sitting on stacks of PHQ-9 scores and intake assessments that nobody revisits, you are not alone. But you are leaving clinical insight, client trust, and commercial leverage on the table.

The Data Paradox: Why Clinics Collect Outcomes but Never Look at Them

Here is the uncomfortable truth. Most practices have a measurement problem, but it is not a lack of data. It is a lack of use. A national survey of 504 US clinicians by Jensen-Doss and colleagues found that only 13.9% used standardised progress measures at least monthly and 61.5% never used them, even though most held positive attitudes towards monitoring and feedback. The scores get captured at intake, maybe again at discharge, and then they sit in a PDF, a spreadsheet, or a forgotten corner of the EHR.

The pattern is remarkably consistent. A new client completes a battery of questionnaires. The clinician glances at the total score, perhaps notes "moderate depression" in the intake summary, and moves on. Six months later, the same client completes a discharge form. Someone files it. Nobody compares the two numbers, let alone tracks the trajectory in between.

This is not a failure of intention. Most clinicians genuinely want to be evidence-based. The failure is structural. The tools we use to collect data were never designed to surface it at the moment it matters: the next session, the clinical decision, the conversation about whether therapy is working. Collecting data and using data are entirely different activities, and the gap between them is where clinical and commercial value disappears.

If that gap sounds familiar, the concept of routine outcome monitoring offers a clear way to close it.

What Routine Outcome Monitoring Actually Is (and Is Not)

Routine outcome monitoring, or ROM, is the systematic, repeated measurement of client outcomes across the course of therapy, with the explicit purpose of feeding that data back into clinical decision-making. It is not a one-off pre/post snapshot. It is not an audit-driven exercise to satisfy commissioners. And it is not a research protocol layered onto everyday practice.

At its core, ROM is a session-by-session clinical feedback loop. A client completes a brief measure before or after each session. The clinician reviews the score, ideally in real time. If a client is not improving, or is deteriorating, the clinician knows immediately, not weeks or months later when the damage is done.

Lambert's Foundational Insight

Michael Lambert's work at Brigham Young University established the intellectual foundation for ROM. His research demonstrated that therapists are surprisingly poor at detecting client deterioration through clinical judgement alone. In one study of 550 clients, therapists predicted that 3 would deteriorate; 40 actually did, and therapists had correctly identified only one of them (Hannan et al., 2005). ROM exists precisely to correct this blind spot.

The distinction matters because many practices believe they already "do" outcome monitoring. If your team administers the PHQ-9 at intake and discharge, that is assessment. If your team administers the PHQ-9 every session and uses the trajectory to guide treatment decisions, that is ROM. The difference is not the measure. It is the feedback loop. As we explored in our guide to measurement-based care in 2026, the clinical value lives in the loop, not in the questionnaire.

The Evidence: Does ROM Improve Outcomes?

The short answer is yes, particularly for clients who are not responding to treatment. The longer answer requires some nuance.

Lambert and colleagues conducted a series of large-scale studies demonstrating that ROM with clinical feedback significantly reduced deterioration rates. In a meta-analysis of 24 studies, feedback practices reduced deterioration rates and nearly doubled rates of clinically significant or reliable change in clients predicted to have a poor outcome (Lambert et al., 2018). Shimokawa, Lambert, and Smart reanalysed data from six studies (6,151 clients) and found that feedback interventions improved outcomes, especially for clients flagged as at risk of treatment failure.

Where the Effect Is Strongest

The evidence is clearest for clients who are off track, meaning those who are not improving at the expected rate or who are actively deteriorating. For these individuals, ROM functions as an early warning system. Without it, clinicians tend to assume things are going well, a blind spot that Lambert's research has repeatedly documented. With it, clinicians can adjust interventions, revisit the therapeutic alliance, or consider referral before the client disengages entirely.

For clients who are already on track, the gains from ROM are smaller. This is worth being honest about. ROM is not a magic multiplier for every therapeutic encounter. Its power lies in preventing harm and rescuing stalled treatments, not in accelerating outcomes that are already progressing well.

The Real-Time Condition

One crucial moderator is timing. The effect of ROM is strongest when feedback reaches the clinician before or during the session, not in a weekly report or quarterly review. Feedback can only change the course of treatment if the clinician sees it while there is still time to act. This has direct implications for implementation: ROM that generates a report nobody reads until next month is barely better than no ROM at all.

Why Most ROM Implementations Fail in Private Practice

If the evidence is this strong, why aren't more practices doing it well? The answer is not clinician resistance alone, though that plays a role. It is that the infrastructure of most private practices actively works against effective ROM.

The Paper and PDF Problem

Many practices still administer measures on paper. A client fills in a questionnaire in the waiting room, the clinician glances at it, and it goes into a file. There is no scoring automation, no trend visualisation, no alert when a score drops. Even practices using electronic health records often find that their EHR captures scores as static data points, not as dynamic trajectories. The score sits in a field alongside the session note, invisible unless someone actively goes looking for it.

This creates what we might call a "data graveyard." The numbers exist, but they are buried. No dashboard surfaces them. No algorithm flags the client whose ORS score has dropped three sessions in a row. The clinician, already managing a full caseload, has no practical way to synthesise trends across 30 or 40 active clients without dedicating hours to manual review.

Feedback Fatigue and Clinician Resistance

There is also a human dimension. Boswell and colleagues describe how clinicians can disengage from outcome data when it feels like an administrative task rather than a clinical tool. This is especially acute when measures are experienced as externally imposed, when clinicians did not choose the instruments, when the data flows upward to management but never back to the therapist, or when the measures feel disconnected from the therapeutic model in use.

Resistance is not irrational. A clinician who practises IFS or ACT may genuinely question whether a PHQ-9 score captures the kind of change they are working toward. That scepticism is clinically valid, and it points to the importance of selecting measures that align with the therapeutic framework. If you have ever questioned whether standard outcome measures capture what matters, our article on tracking psychological flexibility as a clinical KPI explores this tension in depth.

Choosing the Right Measures: PHQ, GAD, ORS, and Beyond

The measure you choose shapes everything: clinician buy-in, client burden, the kind of change you detect, and the conversations you can have. There is no single best instrument. The right choice depends on your clinical model, your client population, and how you intend to use the data.

The Standard Symptom Measures

The PHQ-9 (Patient Health Questionnaire, 9 items) and the GAD-7 (Generalised Anxiety Disorder, 7 items) are the most widely used symptom-specific measures in routine care. Both are free to use, psychometrically robust, and well-validated across populations (Kroenke et al., 2001; Spitzer et al., 2006). They are excellent for tracking symptom severity in depression and anxiety, respectively, and they are the measures most insurance bodies and commissioners recognise.

Their limitation is scope. The PHQ-9 measures depressive symptoms, not wellbeing, not functioning, not the broader therapeutic change many practitioners target. For a practice focused on personal growth, relational health, or values-based living, symptom measures alone will miss much of the picture.

Low-Burden Transdiagnostic Options

The Outcome Rating Scale (ORS) and its companion, the Session Rating Scale (SRS), developed by Scott Miller and Barry Duncan, are designed specifically for session-by-session ROM. The ORS is just four visual analogue items covering individual wellbeing, interpersonal functioning, social role, and overall sense of wellbeing. It takes under a minute to complete. The SRS measures the therapeutic alliance in four items.

Together, they form the core of the Partners for Change Outcome Management System (PCOMS). The appeal is obvious: minimal burden, immediate scoring, and direct relevance to the therapeutic relationship. The trade-off is lower specificity. The ORS will not tell you whether a client's anxiety has improved; it will tell you whether the client feels their life is getting better. For many private practices, that is precisely the level of resolution they need.

ACT-Specific Measures

For practices grounded in Acceptance and Commitment Therapy, the CompACT (Comprehensive Assessment of Acceptance and Commitment Therapy Processes) offers a 23-item measure of psychological flexibility across three domains: openness to experience, behavioural awareness, and valued action (Francis et al., 2016). It is more granular than the older AAQ-II (Acceptance and Action Questionnaire), which has faced psychometric criticism for potentially measuring distress rather than experiential avoidance (Wolgast, 2014).

The CompACT is a stronger choice for ACT-oriented ROM because it tracks the processes of change the model actually targets. If your clinical model emphasises psychological flexibility, measuring only symptom reduction is like judging a restaurant solely by the speed of service. You are missing the thing that matters most.

Licensing Considerations

A practical note: some measures carry licensing fees. The ORS/SRS are free for individual practitioners using paper forms, but agency use and any electronic or digital administration require a paid licence or an authorised vendor. The PHQ-9 and GAD-7 are freely available. The CompACT is available for clinical use without a fee. Before building a ROM workflow around a specific measure, check the licensing terms, particularly if you plan to embed the measure in digital tools or client-facing platforms.

From Numbers to Conversations: Using ROM Data in Session

This is where ROM transforms from an administrative exercise into a clinical one. The moment a clinician shares outcome data with a client and invites reflection, the measure stops being a form and becomes a therapeutic tool.

Score Trajectories as Conversation Starters

Consider a simple scenario. A client's ORS score has been steadily climbing over six sessions, then drops sharply in session seven. Without ROM, the clinician might not notice. The client might not volunteer it. With ROM, the dip is visible, and the clinician can name it: "I noticed your score dropped this week. What do you make of that?"

That question opens a door. Maybe the client had a difficult week. Maybe last session's exploration triggered something unresolved. Maybe the therapeutic relationship has hit a rough patch. Prescott and colleagues argue that sharing outcome data with clients can strengthen the therapeutic alliance, particularly when clients felt their therapist was genuinely responsive to the feedback rather than merely collecting it.

Integrating ROM With IFS and ACT Frameworks

ROM data becomes even richer when interpreted through the lens of a specific therapeutic model. In IFS-informed practice, a score dip might prompt curiosity about which parts are activated: "It looks like something shifted this week. I wonder if a protector part has shown up that we haven't met yet." This is not imposing the data on the client; it is using the data to deepen the therapeutic conversation.

In ACT, a stagnant score on the CompACT's valued action subscale might signal that the client is building awareness and openness but not yet translating that into behavioural change. That is clinically useful information. It tells you where the work needs to go next. If you are exploring how IFS and digital tools can reinforce each other, our piece on why IFS needs digital platforms offers further perspective.

When Clients Resist the Measures

Not every client will embrace ROM. Some will find the measures reductive. Others will feel anxious about "performing" on a questionnaire. This resistance is itself clinically meaningful. A client who says "I can't reduce how I feel to a number" is telling you something important about their relationship with evaluation, judgement, or simplification. The skilful clinician explores the resistance rather than overriding it.

The Commercial Case: How ROM Strengthens Your Practice

Clinical value aside, ROM generates a form of business intelligence that most practices lack entirely. If you can demonstrate, with data, that your interventions work, every commercial conversation changes.

Insurance and Referral Source Negotiations

Insurance bodies and employee assistance programmes increasingly ask for evidence of effectiveness. A practice that can show aggregated, anonymised outcome trajectories across its caseload has a fundamentally different negotiating position from one that says "our clients generally do well." Specific numbers, such as "72% of our anxiety clients show reliable improvement within 8 sessions," move conversations from impressions to evidence.

Referral sources, whether GPs, psychiatrists, or corporate wellness programmes, face the same dynamic. They want to refer to practitioners who can demonstrate results. ROM gives you the data to make that case without overstating clinical claims.

Reducing Dropout by Catching Disengagement Early

Client dropout is one of the most expensive problems in private practice. A meta-analysis of 669 studies found that around one in five adult therapy clients (19.7%) drop out prematurely (Swift and Greenberg, 2012). ROM provides an early signal. A client whose scores are flat or declining is at higher risk of disengagement. A client whose SRS alliance score dips may be losing confidence in the therapeutic relationship. Catching these signals in real time allows the clinician to intervene before the client simply stops booking.

ROM can help practices spot clients who are at risk of disengaging, and as we detailed in our analysis of client retention metrics that matter, even small improvements in retention compound into significant revenue impact over time.

Ethical Marketing Claims

ROM data also supports ethical marketing. Rather than vague claims like "transformative healing" or "life-changing results," a practice with ROM data can say: "Across 200 completed treatment episodes, our average client moved from clinical to non-clinical range on the PHQ-9." That is specific, defensible, and far more compelling to the evidence-minded clients who are increasingly the norm in private practice.

Service Design Decisions

Aggregated ROM data can reveal patterns invisible at the individual level. Perhaps clients in your eight-session anxiety programme plateau at session five, suggesting the programme needs restructuring. Perhaps outcomes differ significantly between clinicians, flagging a supervision or training need. Perhaps a new group intervention is producing stronger results than expected, warranting expansion. None of these insights are available without systematic outcome data.

Building a ROM Workflow That Doesn't Burn Out Your Team

The best ROM system is the one your team actually uses. Ambition kills more ROM implementations than apathy does. Here is a pragmatic, step-by-step approach.

Step 1: Choose Your Measure and Frequency

Start with one measure. Not three. Not a battery. One measure that aligns with your therapeutic model and takes under two minutes to complete. For most private practices, the ORS or the PHQ-9 is a sensible starting point. For ACT-oriented clinics, the CompACT is worth the slightly higher time investment.

Frequency matters. Session-by-session measurement provides the richest data and the most sensitive feedback loop. But if that feels overwhelming, every second or third session is far better than intake-and-discharge only. Some practices adopt a "first five minutes" protocol: the client completes the measure in the waiting room or on a device, and the score is visible to the clinician before the session begins.

Step 2: Automate Delivery and Scoring

Manual scoring is where ROM goes to die. If a clinician has to add up items, look up cut-off scores, and manually plot a graph, it will not happen consistently across a full caseload. Digital delivery, whether through a dedicated ROM platform, an integrated EHR feature, or a between-session engagement tool, removes the friction. The client taps responses on a screen. The score appears instantly. The trend line updates automatically.

Step 3: Set Clinical Cut-Offs and Alerts

Define what "off track" means for your practice. Lambert's system uses expected treatment response curves to flag clients who are deviating from projected improvement. A simpler approach: set a threshold for score change that triggers a visual alert. For the PHQ-9, a change of 6 points or more is the reliable change threshold used in NHS Talking Therapies. For the ORS, a change of 5 points or more is typically treated as reliable change (Miller et al., 2003).

The alert should be visible, brief, and actionable. A red flag on a dashboard. An email notification. Something that says: "This client needs your attention." Not a 10-page report.

Step 4: Make It Visible Without Overwhelming

Clinicians need a dashboard they can scan in 30 seconds before a session. Key information: the client's current score, the trend over the last five sessions, and whether they are flagged as off track. Everything else is optional. The temptation to build elaborate analytics dashboards is strong, but clinical ROM should prioritise simplicity at the point of care and depth only for those who want to dig deeper.

Step 5: Pilot With Willing Clinicians First

Do not mandate ROM across your entire practice on day one. Identify two or three clinicians who are curious, perhaps those already interested in evidence-based practice or frustrated by flying blind. Let them pilot the workflow for eight to twelve weeks. Collect their feedback. Adjust. Then expand. Clinician-led adoption beats top-down mandates every time. Clinician buy-in tends to grow once people see the clinical value of the data for themselves.

Step 6: Budget Five Minutes, Not Fifteen

The entire ROM touchpoint, from client completion to clinician review, should take five minutes or less per session. If it takes longer, something is wrong with the workflow. The measure is too long, the scoring is manual, or the data is not surfaced accessibly. Protect session time. ROM should enhance the clinical hour, not cannibalise it.

Where Digital Therapeutics Fit Into the ROM Stack

Traditional ROM captures a snapshot at one moment: just before or after a session. But therapeutic change does not happen only in the consulting room. It happens between sessions, in the moments when a client practises a new behaviour, confronts an old pattern, or notices a shift in how they relate to their own experience.

Continuous Data vs. Point-in-Time Snapshots

Between-session digital tools can collect what we might call micro-outcome data: daily mood logs, values-alignment check-ins, brief reflections after completing an exercise. This data enriches the ROM picture dramatically. Instead of knowing only that a client's ORS score dropped between session six and session seven, the clinician can see that the drop coincided with three consecutive days of low mood following a specific between-session exercise. That is actionable clinical intelligence.

This is the logic behind the blended therapy model, where in-session work and between-session engagement form a continuous feedback loop rather than two disconnected activities. The digital tool becomes an extension of the therapeutic relationship, not a replacement for it.

Platforms like Afterglow are designed with this integration in mind, connecting between-session engagement (ACT-based exercises, IFS parts awareness check-ins, mood tracking) with outcome data that clinicians can review before each session. It is one approach among several, but it illustrates the direction the field is moving: from episodic measurement to continuous clinical awareness.

The Data Quality Question

A fair concern: does more data always mean better data? Not necessarily. Between-session measures need to be carefully designed to avoid survey fatigue and ensure that what is captured is clinically meaningful rather than merely voluminous. The goal is not to drown clinicians in numbers but to provide a richer, more textured understanding of the client's week than a single score can offer. Quality of data architecture matters as much as quantity of data points.

The Practice That Measures Is the Practice That Leads

We are entering a period where the expectations placed on therapeutic practices are shifting rapidly. Payers are demanding outcome data. Regulatory frameworks for digital therapeutics are tightening. Clients, influenced by a culture of quantified self-tracking, increasingly expect to see evidence that their investment is producing results.

Practices that have mature ROM systems will be ready for these shifts. Those that do not will find themselves scrambling to produce evidence they never collected, or worse, unable to differentiate themselves in a market that increasingly rewards transparency.

But the deepest argument for ROM is not commercial. It is clinical. The therapist who tracks outcomes is the therapist who catches the client slipping through the cracks. Who notices that their favourite intervention is not working for a particular subgroup. Who can say, with confidence, "here is what I do well, and here is where I need to grow."

That is not compliance. It is integrity. And in a field built on trust, integrity is the most durable competitive advantage there is.

References

  • Boswell, J. F., Kraus, D. R., Miller, S. D., and Lambert, M. J. (2015). Implementing routine outcome monitoring in clinical practice: benefits, challenges, and solutions. Psychotherapy Research, 25(1), 6–19.
  • Francis, A. W., Dawson, D. L., and Golijani-Moghaddam, N. (2016). The development and validation of the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT). Journal of Contextual Behavioral Science, 5(3), 134–145.
  • Hannan, C., Lambert, M. J., Harmon, C., Nielsen, S. L., Smart, D. W., Shimokawa, K., and Sutton, S. W. (2005). A lab test and algorithms for identifying clients at risk for treatment failure. Journal of Clinical Psychology, 61(2), 155–163.
  • Jensen-Doss, A., Haimes, E. M. B., Smith, A. M., Lyon, A. R., Lewis, C. C., Stanick, C. F., and Hawley, K. M. (2018). Monitoring treatment progress and providing feedback is viewed favorably but rarely used in practice. Administration and Policy in Mental Health and Mental Health Services Research, 45(1), 48–61.
  • Kroenke, K., Spitzer, R. L., and Williams, J. B. W. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.
  • Lambert, M. J. (2010). Prevention of Treatment Failure: The Use of Measuring, Monitoring, and Feedback in Clinical Practice. American Psychological Association.
  • Lambert, M. J., Whipple, J. L., and Kleinstäuber, M. (2018). Collecting and delivering progress feedback: a meta-analysis of routine outcome monitoring. Psychotherapy, 55(4), 520–537.
  • Miller, S. D., Duncan, B. L., Brown, J., Sparks, J. A., and Claud, D. A. (2003). The Outcome Rating Scale: a preliminary study of the reliability, validity, and feasibility of a brief visual analog measure. Journal of Brief Therapy, 2(2), 91–100.
  • Prescott, D. S., Maeschalck, C. L., and Miller, S. D. (2017). Feedback-Informed Treatment in Clinical Practice: Reaching for Excellence. American Psychological Association.
  • Shimokawa, K., Lambert, M. J., and Smart, D. W. (2010). Enhancing treatment outcome of patients at risk of treatment failure: meta-analytic and mega-analytic review of a psychotherapy quality assurance system. Journal of Consulting and Clinical Psychology, 78(3), 298–311.
  • Spitzer, R. L., Kroenke, K., Williams, J. B. W., and Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
  • Swift, J. K., and Greenberg, R. P. (2012). Premature discontinuation in adult psychotherapy: a meta-analysis. Journal of Consulting and Clinical Psychology, 80(4), 547–559.
  • Wolgast, M. (2014). What does the Acceptance and Action Questionnaire (AAQ-II) really measure? Behavior Therapy, 45(6), 831–839.